Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16066-97-0

Post Buying Request

16066-97-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16066-97-0 Usage

Uses

4-(2-Methyl-2-nitropropyl)phenol is an intermediate in the synthesis of beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor for the treatment of obesity.

Check Digit Verification of cas no

The CAS Registry Mumber 16066-97-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,6 and 6 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 16066-97:
(7*1)+(6*6)+(5*0)+(4*6)+(3*6)+(2*9)+(1*7)=110
110 % 10 = 0
So 16066-97-0 is a valid CAS Registry Number.

16066-97-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2-Methyl-2-nitropropyl)phenol

1.2 Other means of identification

Product number -
Other names 1-nitro-1,1-dimethyl-2-(4-hydroxyphenyl]ethane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16066-97-0 SDS

16066-97-0Relevant articles and documents

Combination of a beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor for the treatment of obesity

Jesudason, Cynthia D.,Baker, James E.,Bryant, Robert D.,Fisher, Jack W.,O'Farrell, Libbey S.,Gaich, Gregory A.,He, Minxia M.,Kahl, Steven D.,Kriauciunas, Aidas V.,Heiman, Mark L.,Peters, Mary A.,Rito, Christopher J.,Satterwhite, Julie H.,Tinsley, Frank C.,Trankle, William G.,Shuker, Anthony J.

, p. 583 - 586 (2011)

We report the novel combination of a selective beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor (sibutramine) with potential for the treatment of obesity. The synthesis and characterization of 6-[4-[2-[[(2S)-3-(9H-carbazol-4-ylo

BENZOTHIAZOLONE COMPOUND

-

Paragraph 38; 39, (2013/03/26)

The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form(I) a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination o

(ALPHA-SUBSTITUTED ARALKYLAMINO AND HETEROARYLALKYLAMINO) PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN TREATING PROLIFERATIVE DISEASES

-

Page/Page column 76, (2012/10/08)

Provided herein are (alpha-substituted aralkylamino or heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, e.g., a compound of Formula 1, and their pharmaceutical compositions, preparation, and use as agents or drugs for treating proliferative diseases

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16066-97-0